Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription 13.05.2024 1 Biol Psychiatry 1 Cereb Cortex 2 Compr Psychiatry 1 Mol Psychiatry 1 Pharmacopsychiatry 2 PLoS One 3 Psychiatry Res 1 Psychol Med 4 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biol Psychiatry

1. LU T, Chen Y, Yoshiji S, Ilboudo Y, et al
   Circulating metabolite abundances associated with risks of bipolar disorder, schizophrenia, and depression: a Mendelian randomization study.
   Biol Psychiatry. 2024 May 3:S0006-3223(24)01285.
   PubMed         Abstract available
   
   

   
   Cereb Cortex

2. YANG X, Liu N, Sun H, Li X, et al
   Sex-related cortical asymmetry in antipsychotic-naive first-episode schizophrenia.
   Cereb Cortex. 2024;34:bhae173.
   PubMed         Abstract available
   
   

   
   Compr Psychiatry

3. DE FILIPPIS R, Aloi M, Liuzza MT, Pugliese V, et al
   Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia.
   Compr Psychiatry. 2024;133:152496.
   PubMed         Abstract available
   
   
4. SHI X, Sun X, Zhang C, Li Z, et al
   Individual stigma in people with severe mental illness: Associations with public stigma, psychological capital, cognitive appraisal and coping orientations.
   Compr Psychiatry. 2024;132:152474.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

5. STERN S, Zhang L, Wang M, Wright R, et al
   Monozygotic twins discordant for schizophrenia differ in maturation and synaptic transmission.
   Mol Psychiatry. 2024 May 4. doi: 10.1038/s41380-024-02561.
   PubMed         Abstract available
   
   

   
   Pharmacopsychiatry

6. KOMATSU Y, Takehara M, Hart X, Takahashi Y, et al
   Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments.
   Pharmacopsychiatry. 2024 May 6. doi: 10.1055/a-2307-6484.
   PubMed         Abstract available
   
   

   
   PLoS One

7. MUSLIH M, Chung MH
   Structural validity of the Rosenberg self-esteem scale in patients with schizophrenia in Indonesia.
   PLoS One. 2024;19:e0300184.
   PubMed         Abstract available
   
   
8. HANLON C, Roberts T, Misganaw E, Malla A, et al
   Studying the context of psychoses to improve outcomes in Ethiopia (SCOPE): Protocol paper.
   PLoS One. 2024;19:e0293232.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

9. GUO H, Zhong S, Lam ST, Wang N, et al
   Trends in violent offending among people with schizophrenia: A 10-year ecological study.
   Psychiatry Res. 2024;337:115935.
   PubMed         Abstract available
   
   
10. WU Y, Zhang CY, Zhang Y, Chen R, et al
    Genomic landscape and functional characterization of structural variations in schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;337:115929.
    PubMed         Abstract available
    
    
11. ROTELLA F, Falone A, Cassioli E, Mannucci E, et al
    The effect of differences in trial design on estimates of efficacy of olanzapine in randomized studies.
    Psychiatry Res. 2024;336:115895.
    PubMed         Abstract available
    
    

    
    Psychol Med

12. SELTEN JP, Di Forti M, Quattrone D, Jones PB, et al
    The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.
    Psychol Med. 2024 May 9:1-10. doi: 10.1017/S0033291724001004.
    PubMed         Abstract available
    
    

    
    Schizophr Res

13. LI N, Li Y, Yu T, Gou M, et al
    Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia.
    Schizophr Res. 2024;269:36-47.
    PubMed         Abstract available
    
    
14. WANG Y, Xu Y, Wu P, Zhou Y, et al
    Exploring the interplay between core and mood symptoms in schizophrenia: A network analysis.
    Schizophr Res. 2024;269:28-35.
    PubMed         Abstract available
    
    
15. SHIMADA T, Morimoto T, Nagayama H, Nakamura N, et al
    Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial.
    Schizophr Res. 2024;269:18-27.
    PubMed         Abstract available
    
    
16. ZHANG C, Liang J, Yan H, Li X, et al
    Fractional amplitude of low-frequency fluctuations in sensory-motor networks and limbic system as a potential predictor of treatment response in patients with schizophrenia.
    Schizophr Res. 2024 May 3:S0920-9964(24)00173.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.